Cephalexin Monohydrate Suspension
Treatment of Otitis Media
- Samuel E. McLinn, MD;
- James F. Daly Jr., MD;
- James E. Jones, MD
Abstract
Cephalexin monohydrate suspension was used in the treatment of 97 children with otitis media. Pretreatment middle-ear exudate specimens in pure or mixed culture yielded Diplococcus pneumoniae in 47 cases, Haemophilus influenzae in 26, Neisseria catarrhalis in 20, group A β-hemolytic streptococci in 13, and Staphylococcus aureus in one. The usual dosage was 100 mg/kg/day given orally in divided doses for 10 to 12 days.
After 48 hours of treatment, follow-up cultures showed that therapy had been successful in 90 children; 81 remained clinically and bacteriologically free of disease for at least three weeks following therapy. Of the seven children for whom therapy failed, H influenzae persisted in five and D pneumoniae in two. Acceptance of the drug was entirely satisfactory with no important side effects encountered.
(JAMA 234:171-173, 1975)
Footnotes
-
Reprint requests to Uptown Professional Bldg, Suite 150, 2645 N Third St, Harrisburg, PA 17110 (Dr. McLinn).
